DRREDDY.NS Cash Flow
Dr. Reddy's Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 9 years on file
(FY2017-18 to FY2025-26)
· fetched 2026-08-23 21:45
| Line item | FY2017-18 | FY2018-19 | FY2019-20 | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | N/A | N/A | N/A | N/A | ₹2,810.80 Cr. | ₹5,887.30 Cr. | ₹4,543.30 Cr. | ₹4,642.80 Cr. | ₹5,673.70 Cr. | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | N/A | N/A | N/A | N/A | ₹-2,638.70 Cr. | ₹-4,137.10 Cr. | ₹-4,028.30 Cr. | ₹-5,102.10 Cr. | ₹-6,549.30 Cr. | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | N/A | N/A | N/A | N/A | ₹-242.20 Cr. | ₹-2,686.10 Cr. | ₹-376.30 Cr. | ₹1,185.50 Cr. | ₹829.00 Cr. | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | N/A | N/A | N/A | N/A | ₹73.30 Cr. | ₹28.60 Cr. | ₹-5.90 Cr. | ₹22.40 Cr. | ₹124.10 Cr. | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | N/A | N/A | N/A | N/A | ₹3.20 Cr. | ₹-907.30 Cr. | ₹132.80 Cr. | ₹748.60 Cr. | ₹77.50 Cr. | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | N/A | N/A | N/A | N/A | ₹1,482.00 Cr. | ₹1,485.20 Cr. | ₹577.90 Cr. | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from DRREDDY.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).